EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis

Alessandro Cannavo, Marika Comegna, Alice Castaldo, Caterina Vinciguerra, Anna Lauritano, Giulia Renata Franco, Giovanna Casoria, Graziamaria Corbi, Giuseppe Rengo, Giuseppe Castaldo

Pulmonary Pharmacology & Therapeutics · 2025

DOI: 10.1016/j.pupt.2025.102385 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pulmonary Pharmacology & Therapeutics, 2025. Verfasst von Alessandro Cannavo und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: alessandro.cannavo@unina.it. Hauptthemen laut MEDLINE: Cystic Fibrosis, Receptors, Adrenergic, beta-2, Receptors, Adrenergic, beta-3. Die Arbeit nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Naples Federico II.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cystic fibrosis (CF) is an autosomal recessive disorder that affects multiple organs, with clinical manifestations, disease progression, and response to therapy varying among individuals. This effect is mainly caused by mutations in the gene encoding for the CF transmembrane conductance regulator (CFTR), a cAMP-regulated chloride channel. In recent decades, other genes and their allelic variants, beyond CFTR mutations, have been proposed as genetic modifiers of CF phenotype. For instance, different polymorphic β2-adrenergic receptor (β2AR) polymorphic variants have been reported in CF individuals and appear to influence correct receptor function. β2AR belongs to the βAR family, which includes three subtypes: β1AR, β2AR, and β3AR. These receptors are crucial G protein-coupled receptors (GPCRs) expressed in various cell types and serve as key modulators of cAMP production, making their function particularly relevant in CF pathophysiology. β2AR is abundantly expressed in airway epithelial and smooth muscle cells, and studies revealed that it plays a crucial role in modulating CFTR activity and smooth muscle contractility through cAMP signaling. For these reasons, β2-agonists are widely used in clinical healthcare to treat patients with obstructive airway disorders, including CF. Emerging evidence has also supported a role for β3AR, which is expressed in the canine and human bronchial epithelium and have been reported to enhance ciliary motility and regulate CFTR function, making it a potential therapeutic target in CF.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisReceptors, Adrenergic, beta-2Receptors, Adrenergic, beta-3HumansAnimalsCystic Fibrosis Transmembrane Conductance RegulatorCyclic AMPMutationAdrenergic beta-2 Receptor Agonists

Stichwörter der Autor:innen

Beta-adrenergic receptorCFTRCystic fibrosisSingle nucleotide polymorphismβ2-agonists

Substanzen

Receptors, Adrenergic, beta-2Cystic Fibrosis Transmembrane Conductance RegulatorReceptors, Adrenergic, beta-3Cyclic AMPAdrenergic beta-2 Receptor Agonists

Autor:innen und Institutionen

  • Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: alessandro.cannavo@unina.it.
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II Naples, Italy; CEINGE-Biotecnologie Avanzate Franco Salvatore, 80145, Naples, Italy.
  • Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy; SC di Pneumologia e UTSIR, AORN Santobono-Pausilipon, Naples, Italy.
  • Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
  • Department of Molecular Medicine and Medical Biotechnology, University of Naples Federico II Naples, Italy.

Förderung

  • University of Naples Federico II

Zitieren

APA

Cannavo, A., Comegna, M., Castaldo, A., Vinciguerra, C., Lauritano, A., Franco, G. R., Casoria, G., Corbi, G., Rengo, G., & Castaldo, G. (2025). Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis. Pulmonary Pharmacology & Therapeutics. https://doi.org/10.1016/j.pupt.2025.102385

Vancouver

Cannavo A, Comegna M, Castaldo A, Vinciguerra C, Lauritano A, Franco GR, et al. Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis. Pulmonary Pharmacology & Therapeutics. 2025. doi:10.1016/j.pupt.2025.102385

BibTeX
@article{Cannavo2025,
  author = {Cannavo, Alessandro and Comegna, Marika and Castaldo, Alice and Vinciguerra, Caterina and Lauritano, Anna and Franco, Giulia Renata and Casoria, Giovanna and Corbi, Graziamaria and Rengo, Giuseppe and Castaldo, Giuseppe},
  title = {Exploring the role of β2- and β3-adrenergic receptors in cystic fibrosis},
  journal = {Pulmonary Pharmacology & Therapeutics},
  year = {2025},
  doi = {10.1016/j.pupt.2025.102385}
}
Kostenlos starten →